Telomir Pharmaceuticals, Valuation
| TELO Stock | 4.91 0.03 0.61% |
At this time, the company appears to be overvalued. Telomir Pharmaceuticals, has a current Real Value of USD4.29 per share. The regular price of the company is USD4.91. Our model measures the value of Telomir Pharmaceuticals, from inspecting the company fundamentals such as Return On Equity of -17.53, shares outstanding of 29.75 M, and Number Of Shares Shorted of 650.6 K as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Telomir Pharmaceuticals,'s valuation include:
Price Book 332.4742 | Enterprise Value 147.1 M |
Overvalued
Today
Please note that Telomir Pharmaceuticals,'s price fluctuation is very risky at this time. Calculation of the real value of Telomir Pharmaceuticals, is based on 3 months time horizon. Increasing Telomir Pharmaceuticals,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Telomir Pharmaceuticals, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Telomir Stock. However, Telomir Pharmaceuticals,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.91 | Real 4.29 | Hype 4.91 |
The intrinsic value of Telomir Pharmaceuticals,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Telomir Pharmaceuticals,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Telomir Pharmaceuticals, Common helps investors to forecast how Telomir stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Telomir Pharmaceuticals, more accurately as focusing exclusively on Telomir Pharmaceuticals,'s fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Telomir Pharmaceuticals,'s intrinsic value based on its ongoing forecasts of Telomir Pharmaceuticals,'s financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Telomir Pharmaceuticals,'s closest peers.
Telomir Pharmaceuticals, Cash |
|
Telomir Valuation Trend
Knowing Telomir Pharmaceuticals,'s actual value is paramount for traders when making sound investment determinations. Using both Telomir Pharmaceuticals,'s enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Telomir Valuation Data Drivers
Telomir Pharmaceuticals, Total Value Analysis
Telomir Pharmaceuticals, Common is at this time expected to have valuation of 147.08 M with market capitalization of 146.98 M, debt of 101 K, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Telomir Pharmaceuticals, fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
147.08 M | 146.98 M | 101 K |
Telomir Pharmaceuticals, Asset Utilization
One of the ways to look at asset utilization of Telomir is to check how much profit was generated for every dollar of assets it reports. Telomir Pharmaceuticals, has a negative utilization of assets of -2.05 %, losing USD0.0205 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Telomir Pharmaceuticals, Common shows how discouraging it operates for each dollar spent on its assets.Telomir Pharmaceuticals, Ownership Allocation
Telomir Pharmaceuticals, shows a total of 29.75 Million outstanding shares. Telomir Pharmaceuticals, maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Telomir Pharmaceuticals, Profitability Analysis
Net Loss for the year was (13.07 M) with profit before overhead, payroll, taxes, and interest of 0.About Telomir Pharmaceuticals, Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Telomir Pharmaceuticals, Common. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Telomir Pharmaceuticals, based exclusively on its fundamental and basic technical indicators. By analyzing Telomir Pharmaceuticals,'s financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Telomir Pharmaceuticals,'s intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Telomir Pharmaceuticals,. We calculate exposure to Telomir Pharmaceuticals,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Telomir Pharmaceuticals,'s related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -3.5 M | -3.7 M |
Telomir Pharmaceuticals, Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 29.6 M |
Telomir Pharmaceuticals, Current Valuation Indicators
Telomir Pharmaceuticals,'s valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Telomir Pharmaceuticals,'s valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Telomir Pharmaceuticals,, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Telomir Pharmaceuticals,'s valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Telomir Pharmaceuticals,'s worth.When determining whether Telomir Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Telomir Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Telomir Pharmaceuticals, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Telomir Pharmaceuticals, Common Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telomir Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telomir Pharmaceuticals,. If investors know Telomir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telomir Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.78) | Return On Assets (2.05) | Return On Equity (17.53) |
The market value of Telomir Pharmaceuticals, is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telomir Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telomir Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telomir Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.